|
1
|
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.
|
Proc Natl Acad Sci U S A
|
1985
|
2.35
|
|
2
|
Intracellular distribution of microinjected antisense oligonucleotides.
|
Proc Natl Acad Sci U S A
|
1991
|
2.22
|
|
3
|
Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression.
|
J Biol Chem
|
1995
|
1.64
|
|
4
|
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells.
|
Nucleic Acids Res
|
1986
|
1.62
|
|
5
|
Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
|
Cell Death Differ
|
2000
|
1.49
|
|
6
|
Molecular cloning of a new interferon-induced PML nuclear body-associated protein.
|
J Biol Chem
|
1997
|
1.37
|
|
7
|
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays.
|
Blood
|
2001
|
1.34
|
|
8
|
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.
|
Oncogene
|
2007
|
1.15
|
|
9
|
A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.
|
Nucleic Acids Res
|
2000
|
1.07
|
|
10
|
The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro.
|
Biochemistry
|
2001
|
1.01
|
|
11
|
Cell delivery and mechanisms of action of antisense oligonucleotides.
|
Prog Nucleic Acid Res Mol Biol
|
1993
|
0.95
|
|
12
|
2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites.
|
Virology
|
1983
|
0.95
|
|
13
|
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.
|
FEBS Lett
|
1997
|
0.93
|
|
14
|
Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance.
|
J Gen Virol
|
1983
|
0.90
|
|
15
|
Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.
|
Nucleic Acids Res
|
1991
|
0.89
|
|
16
|
c-myc and c-fos gene regulation during mouse liver regeneration.
|
Oncogene
|
1989
|
0.88
|
|
17
|
IL-6 regulates CD44 cell surface expression on human myeloma cells.
|
Leukemia
|
2004
|
0.87
|
|
18
|
The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28.
|
J Interferon Cytokine Res
|
2000
|
0.86
|
|
19
|
Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein.
|
J Biol Chem
|
2001
|
0.86
|
|
20
|
Antisense inhibitors of HIV: problems and perspectives.
|
Antiviral Res
|
1992
|
0.86
|
|
21
|
In vivo footprints between the murine c-myc P1 and P2 promoters.
|
Oncogene
|
1992
|
0.85
|
|
22
|
The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms.
|
Biochimie
|
1988
|
0.83
|
|
23
|
Assignment of ISG20 encoding a new interferon-induced PML nuclear body-associated protein, to chromosome 15q26 by in situ hybridization.
|
Cytogenet Cell Genet
|
1997
|
0.82
|
|
24
|
Localization of Staf50, a member of the Ring finger family, to 11p15 by fluorescence in situ hybridization.
|
Genomics
|
1996
|
0.81
|
|
25
|
Role of RNA structures in c-myc and c-fos gene regulations.
|
Gene
|
1988
|
0.80
|
|
26
|
[Interferon signaling pathways].
|
Bull Cancer
|
1999
|
0.80
|
|
27
|
Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules.
|
J Interferon Cytokine Res
|
1997
|
0.79
|
|
28
|
Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants.
|
J Biol Chem
|
1984
|
0.79
|
|
29
|
Establishment of the antiviral state in alpha, beta-interferon-resistant Friend cells treated with gamma-interferon. Induction of 67-kilodalton protein kinase activity in absence of detectable 2-5A synthetase.
|
J Biol Chem
|
1985
|
0.77
|
|
30
|
Regulation of c-myc expression by IFN in Burkitt's lymphoma cells.
|
Prog Clin Biol Res
|
1985
|
0.75
|
|
31
|
Isolation and biological characterization of mouse LM fibroblast variants resistant to the cytotoxicity of polyriboinosinic polyribocytidylic acid after interferon treatment.
|
J Gen Virol
|
1984
|
0.75
|
|
32
|
The role of two interferon-induced enzymatic activities in erythroid differentiation of Friend cells.
|
Prog Clin Biol Res
|
1985
|
0.75
|
|
33
|
Subcellular distribution of 2',5'-oligoadenylate synthetase in differentiating Friend leukemia cells.
|
Differentiation
|
1985
|
0.75
|
|
34
|
In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus.
|
Oncogene
|
1989
|
0.75
|